Dr. Michael Jansen, M.D

NPI: 1265878466
Total Payments
$44,975
2024 Payments
$36,648
Companies
28
Transactions
176
Medicare Patients
1,423
Medicare Billing
$591,685

Payment Breakdown by Category

Other$16,678 (37.1%)
Consulting$11,287 (25.1%)
Food & Beverage$10,890 (24.2%)
Travel$6,120 (13.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,000 3 28.9%
Consulting Fee $11,287 5 25.1%
Food and Beverage $10,890 149 24.2%
Travel and Lodging $6,120 11 13.6%
Honoraria $3,091 2 6.9%
Entertainment $586.95 6 1.3%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $18,160 27 $0 (2024)
Ocular Therapeutix, Inc. $7,006 18 $0 (2024)
Genentech USA, Inc. $7,006 26 $0 (2024)
Apellis Pharmaceuticals, Inc. $2,316 8 $0 (2024)
Alimera Sciences, Inc. $2,266 17 $0 (2024)
Alcon Research Ltd $1,620 3 $0 (2018)
Regeneron Pharmaceuticals, Inc. $1,422 5 $0 (2019)
Regeneron Healthcare Solutions, Inc. $1,036 12 $0 (2024)
Optos, Inc. $586.95 6 $0 (2024)
Novartis Pharmaceuticals Corporation $572.57 5 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $36,648 97 Astellas Pharma US Inc ($17,846)
2023 $2,234 42 Genentech USA, Inc. ($542.20)
2022 $383.99 4 Bausch & Lomb Americas Inc. ($159.98)
2021 $716.30 8 Dutch Ophthalmic, USA ($206.24)
2020 $508.50 4 Regeneron Healthcare Solutions, Inc. ($246.76)
2019 $1,877 14 Regeneron Pharmaceuticals, Inc. ($734.35)
2018 $2,608 7 Alcon Research Ltd ($1,620)

All Payment Transactions

176 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,000.00 General
Category: Ophthalmology
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Travel and Lodging Cash or cash equivalent $915.34 General
Category: Ophthalmology
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Travel and Lodging Cash or cash equivalent $400.39 General
Category: Ophthalmology
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Travel and Lodging Cash or cash equivalent $206.12 General
Category: Ophthalmology
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $124.80 General
Category: Ophthalmology
12/11/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $9.92 General
Category: Ophthalmology
12/04/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $86.28 General
Category: Corticosteroid intracanalicular insert
12/03/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $111.69 General
Category: Ophthalmology
11/22/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $21.39 General
Category: Immunology and Ophthalmology
11/20/2024 Astellas Pharma US Inc Izervay (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,000.00 General
Category: Ophthalmology
11/20/2024 Ocular Therapeutix, Inc. Consulting Fee Cash or cash equivalent $2,200.00 General
11/20/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $124.12 General
Category: Ophthalmology
11/18/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $62.99 General
Category: Corticosteroid intracanalicular insert
11/17/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $21.83 General
Category: Corticosteroid intracanalicular insert
11/17/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $15.99 General
Category: Corticosteroid intracanalicular insert
11/15/2024 Ocular Therapeutix, Inc. Travel and Lodging In-kind items and services $1,945.84 General
11/15/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $115.54 General
Category: Corticosteroid intracanalicular insert
11/15/2024 Ocular Therapeutix, Inc. Food and Beverage In-kind items and services $37.00 General
11/15/2024 Ocular Therapeutix, Inc. Food and Beverage In-kind items and services $28.00 General
11/15/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $24.73 General
Category: Corticosteroid intracanalicular insert
11/14/2024 Ocular Therapeutix, Inc. Food and Beverage In-kind items and services $95.00 General
11/14/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $41.91 General
Category: Corticosteroid intracanalicular insert
11/12/2024 Optos, Inc. NFC-700 (Device), PANORAMIC OPHTHALMOSCOPE, OCT OPHTHALMOSCOPE Entertainment In-kind items and services $92.98 General
Category: OPHTHALMOLOGY
10/30/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $26.85 General
Category: Ophthalmology
10/28/2024 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $44.08 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 948 27,965 $778,179 $419,211
2022 9 322 896 $515,155 $158,208
2021 5 138 193 $53,045 $13,554
2020 1 15 20 $3,320 $713.55
Total Patients
1,423
Total Services
29,074
Medicare Billing
$591,685
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2777 Injection, faricimab-svoa, 0.1 mg Office 2023 52 7,260 $317,117 $207,971 65.6%
J0178 Injection, aflibercept, 1 mg Office 2023 33 132 $170,886 $91,250 53.4%
J3490 Unclassified drugs Office 2023 12 17 $55,000 $29,337 53.3%
67028 Injection of drug into eye Office 2023 98 228 $52,074 $21,567 41.4%
92134 Imaging of retina Office 2023 230 434 $34,913 $14,399 41.2%
92014 Established patient complete exam of visual system Office 2023 98 122 $26,406 $12,471 47.2%
92012 Established patient problem focused exam of visual system Office 2023 68 155 $46,500 $11,529 24.8%
J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg Office 2023 23 19,200 $16,896 $10,543 62.4%
92004 New patient complete exam of visual system Office 2023 78 78 $21,327 $9,468 44.4%
92201 Extended exam of the back part of the eye with retinal drawing Office 2023 134 194 $8,647 $3,901 45.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 32 $12,718 $3,148 24.8%
92250 Photography of the retina Office 2023 63 78 $10,745 $2,360 22.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 15 $4,380 $1,024 23.4%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 19 20 $570.20 $242.25 42.5%
J0178 Injection, aflibercept, 1 mg Office 2022 13 146 $295,504 $104,660 35.4%
67028 Injection of drug into eye Office 2022 25 128 $50,432 $14,245 28.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 57 112 $47,152 $12,409 26.3%
92134 Imaging of retina Office 2022 57 172 $27,176 $6,641 24.4%
92250 Photography of the retina Office 2022 72 155 $27,280 $5,361 19.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 31 57 $16,644 $5,016 30.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 31 31 $19,902 $4,764 23.9%
J9035 Injection, bevacizumab, 10 mg Office 2022 14 49 $22,785 $2,618 11.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 22 46 $8,280 $2,494 30.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 38 55 $23,155 $6,313 27.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 14 14 $8,988 $2,305 25.6%

About Dr. Michael Jansen, M.D

Dr. Michael Jansen, M.D is a Ophthalmology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1265878466.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jansen, M.D has received a total of $44,975 in payments from pharmaceutical and medical device companies, with $36,648 received in 2024. These payments were reported across 176 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,000).

As a Medicare-enrolled provider, Jansen has provided services to 1,423 Medicare beneficiaries, totaling 29,074 services with total Medicare billing of $591,685. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Other Specialties Ophthalmology
  • Location Denver, CO
  • Active Since 05/14/2013
  • Last Updated 10/06/2025
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1265878466

Products in Payments

  • Izervay (Drug) $16,990
  • Susvimo (Drug) $3,575
  • Vabysmo (Drug) $3,170
  • ILUVIEN (Drug) $1,621
  • DEXTENZA (Drug) $1,082
  • EYLEA (Biological) $864.37
  • YUTIQ (Drug) $769.42
  • NFC-700 (Device) $486.47
  • Syfovre (Drug) $462.75
  • EVA Ophthalmic Surgical System (Device) $351.03
  • ACTHAR (Biological) $251.47
  • BEOVU (Drug) $237.63
  • EVA, combined machine (Device) $190.94
  • EYLEA HD (Biological) $171.47
  • OZURDEX (Drug) $170.09
  • XIPERE (Drug) $159.98
  • ARTEVO 800 (Device) $156.89
  • Luxor (Device) $149.84
  • VABYSMO (Drug) $148.66
  • LUMIGAN (Drug) $122.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Denver